Viewing StudyNCT00210717



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00210717
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2005-09-13

Brief Title: A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Organization Data

Organization: Johnson Johnson Pharmaceutical Research Development LLC
Class: INDUSTRY
Study ID: CR004195
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators